131 related articles for article (PubMed ID: 1896091)
21. In vitro immune functions in patients with minor, moderate, and severe kidney impairment.
Langhoff E; Ladefoged J
APMIS; 1988 Jul; 96(7):655-9. PubMed ID: 3261594
[TBL] [Abstract][Full Text] [Related]
22. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients.
Memoli B; Postiglione L; Cianciaruso B; Bisesti V; Cimmaruta C; Marzano L; Minutolo R; Cuomo V; Guida B; Andreucci M; Rossi G
Kidney Int; 2000 Jul; 58(1):417-24. PubMed ID: 10886590
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes.
Pertosa G; Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
Kidney Int; 1998 Aug; 54(2):570-9. PubMed ID: 9690225
[TBL] [Abstract][Full Text] [Related]
24. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.
Famularo G; Procopio A; Giacomelli R; Danese C; Sacchetti S; Perego MA; Santoni A; Tonietti G
Clin Exp Immunol; 1990 Sep; 81(3):368-72. PubMed ID: 2397608
[TBL] [Abstract][Full Text] [Related]
25. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
Yamashita T; Boros DL
J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
[TBL] [Abstract][Full Text] [Related]
26. Immune deficiency of the uremic patient.
Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
[No Abstract] [Full Text] [Related]
27. Interleukin-2 deficit in hemodialysis patients. Role of prostaglandins.
Glez-Gutiérrez M; de Francisco AL; Sanz de Castro S; Ruiz JC; Prieto M; García Fuentes M; Arias M
Ren Fail; 1992; 14(4):563-9. PubMed ID: 1462008
[TBL] [Abstract][Full Text] [Related]
28. Production of cytokines in hemodialysis.
Tetta C; Camussi G; Turello E; Salomone M; Aimo G; Priolo G; Segoloni G; Vercellone A
Blood Purif; 1990; 8(6):337-46. PubMed ID: 2093331
[TBL] [Abstract][Full Text] [Related]
29. The effects of the dialysis membrane on cytokine release.
Zaoui P; Hakim RM
J Am Soc Nephrol; 1994 Mar; 4(9):1711-8. PubMed ID: 8011981
[TBL] [Abstract][Full Text] [Related]
30. Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinoma.
Favrot MC; Combaret V; Negrier S; Philip I; Thiesse P; Freydel C; Bijmann JT; Franks CR; Mercatello A; Philip T
J Biol Response Mod; 1990 Apr; 9(2):167-77. PubMed ID: 1971303
[TBL] [Abstract][Full Text] [Related]
31. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
Klingemann HG; Kohn FR; Phillips GL
Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
[TBL] [Abstract][Full Text] [Related]
32. Leukocyte proliferation and immune modulator production in patients with chronic kidney disease.
Mansouri L; Paulsson JM; Moshfegh A; Jacobson SH; Lundahl J
PLoS One; 2013; 8(8):e73141. PubMed ID: 23951343
[TBL] [Abstract][Full Text] [Related]
33. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
34. Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number.
Stachowski J; Pollok M; Burrichter H; Spithaler C; Baldamus CA
Nephron; 1993; 64(3):369-75. PubMed ID: 8101978
[TBL] [Abstract][Full Text] [Related]
35. Accessory cell functions in mononuclear cell cultures uremic patients.
Ladefoged J; Langhoff E
Kidney Int; 1990 Jan; 37(1):126-30. PubMed ID: 2299798
[TBL] [Abstract][Full Text] [Related]
36. Patients on chronic hemodialysis have no intrinsic lymphocyte defect upon stimulation with interleukin-2, interleukin-15 or tumor necrosis factor-alpha.
van Riemsdijk IC; Baan CC; Loonen EH; Zietse R; Weimar W
Blood Purif; 2003; 21(2):158-62. PubMed ID: 12601258
[TBL] [Abstract][Full Text] [Related]
37. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease.
Kaul H; Girndt M; Sester U; Sester M; Köhler H
Am J Kidney Dis; 2000 Apr; 35(4):611-6. PubMed ID: 10739780
[TBL] [Abstract][Full Text] [Related]
38. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells.
Plum J; Fleisch MC; Razeghi P; Fusshöller A; Lordnejad MR; Grabensee B
Kidney Blood Press Res; 2002; 25(4):195-201. PubMed ID: 12424420
[TBL] [Abstract][Full Text] [Related]
39. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C.
Garyfallos A; Raptopoulou-Gigi M; Orphanou H; Spaia S; Petridou P; Vayionas G
J Investig Allergol Clin Immunol; 1995; 5(5):255-8. PubMed ID: 8574431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
